newsfilter
← Latest News
Business Wire·

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors

  • United Therapeutics announced Professor Raymond Dwek's Board term will expire at the 2026 Annual Meeting of Shareholders on June 26, 2026.
  • Prof. Dwek joined the Board in 2002 & witnessed over 1,000% share price appreciation during his tenure.
  • He will transition to the company's Scientific Advisory Board following his Board departure.
  • The Board size will reduce from 13 members to 12 effective at the 2026 Annual Meeting.
  • CEO Martine Rothblatt praised Prof. Dwek's scientific insight & business acumen for driving innovation in pulmonary hypertension, pulmonary fibrosis, neuroblastoma, & lung transplantation.
  • Prof. Dwek highlighted his cherished experience serving the company's quest to improve patient lives through transformative medical innovation.